Delivery Order SPE2DB22D1017-SPE2DB25FG6YR
- Not listed
- This is a delivery order federal contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Cinacalcet HCl 30 mg tablets, with a ceiling value of $9,227.61 and a completion date of July 10, 2025. The contract is not set aside and is a firm fixed-price delivery order. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- The U.S. government awarded a firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of Cinacalcet HCl 30 mg tablets. The $4,260.99 contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of July 8, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of CINACALCET HCL 30 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $6,201.58 and a completion date of April 7, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $7,411.44 and an ultimate completion date of February 19, 2025. It covers the procurement of Cinacalcet HCl 30 mg tablets for federal government medical programs. AmerisourceBergen is an established vendor for the DLA, holding a $999,999,999 Indefinite Delivery...
- This federal contract award is a delivery order worth $1,161.90 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the supply of Cinacalcet HCL 30 mg tablets and has a completion date of February 3, 2025. The contract is not designated as a set-aside and is issued under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,524.40 firm fixed-price delivery order is for 4,567,394,905 units of CINACALCET HCL 30 MG TABLET 30S. The contract has a ceiling value of $5,524.40 and a completion date of February 27, 2025. This contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999 Indefinite...
- This federal contract award, valued at $4,711.64, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, which is not a set-aside, is a delivery order contract for the supply of 4,568,062,253 units of the medication Cinacalcet HCl 30 mg Tablet. The contract has a firm fixed-price pricing type and an ultimate completion date of April 29, 2025. Amerisourcebergen Drug Corp holds a...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Cinacalcet HCl 30 mg tablets, a medication used to treat certain types of hyperparathyroidism. The contract has a firm fixed price of $3,123.92 and a performance period ending on July 10, 2025. This appears to be a non-set-aside contract, meaning it was open to full and...
- This federal contract award is for the delivery of CINACALCET HCL 30 MG TABLET 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $8,501.61, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is December 24, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of CALQUENCE 100 MG TABLET 60S. The contract has a firm fixed price, non-set-aside designation, and a ceiling value of $11,187.56. The period of performance extends to July 15, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FG6YRDelivery Order
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Cinacalcet HCl 30 mg tablets. The contract has a ceiling value of $2,649.80 and a completion date of July 10, 2025. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. This delivery order is likely part of the company's broader role as a critical vendor supporting federal medical procurement needs, particularly for the military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 7/9/25 |